A comparison of the relative expression level of HOTTIP in 30 NPC patients who provided pretreatment and posttreatment serum specimens showed that after treatment, HOTTIP expression decreased in 25 patients and increased in 5 patients (Table 2). The gene discussed is HOTTIP; the disease is nasopharyngeal carcinoma.